XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses:    
Research and development $ 64,542 $ 35,882
General and administrative 23,040 16,720
Total operating expenses 87,582 52,602
Loss from operations (87,582) (52,602)
Other income (expense), net:    
Interest income 167 1,616
Interest expense (2,583)
Total other income (expense), net (2,416) 1,616
Net loss (89,998) (50,986)
Other comprehensive loss:    
Unrealized loss on marketable securities (21) (72)
Total other comprehensive loss (21) (72)
Comprehensive loss $ (90,019) $ (51,058)
Basic and diluted net loss per common share $ (1.27) $ (0.74)
Weighted average common shares outstanding used to calculate basic and diluted net loss per common share 71,055,331 68,893,127